latest news releases from the newsroom
MoCA Expands Membership to Include Texas Instruments
DALLAS, Nov. 6, 2006 (PRIMEZONE) -- TelcoTV -- The Multimedia over Coax Alliance (MoCA(tm)) has announced that Texas Instruments (TI) has joined the organization. By leveraging TI's leadership position across the broadband and consumer electronics markets, MoCA is furthering its efforts to drive home networking of digital video and entertainment.
FORD AT BILIA IN STOCKHOLM
In April of next year, Bilia will start selling and servicing Ford’s product
programme in southern and eastern Stockholm.
These operations will be run at the current dealerships in Segeltorp and Nacka,
which will therefore represent three brands: Volvo, Ford and Renault.
“We are happy to be able to offer customers a more extensive product range. By
utilising existing facilities for an additional brand, we shall be even more
cost effective and this will lead to increased competitive strengt
Encysive Pharmaceuticals Inc.
Encysive Pharmaceuticals Announces Launch of THELIN in United Kingdom
HOUSTON, Nov. 6, 2006 (PRIMEZONE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium)(2) 100 mg tablets in the United Kingdom for the treatment of pulmonary arterial hypertension (PAH). The United Kingdom is the first European Union (EU) country in which Encysive is launching THELIN. The Company was granted marketing authorization for THELIN by the European Commission in August 2006. THELIN is the first selective endothelin A receptor antagonist, and the first once daily oral treatment available for patients with PAH.
XOMA Receives European Certification to Manufacture Investigational Medicinal Products
BERKELEY, Calif., Nov. 6, 2006 (PRIMEZONE) -- XOMA Ltd. (Nasdaq:XOMA) today announced that its cGMP pharmaceutical manufacturing facilities have received Investigational Medicinal Products certification from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom. The MHRA certification approves XOMA's manufacturing facilities for the production of biological investigational medicinal products to be used in clinical trials in the European Union.